# Oscar Health

Type: Company (OSCR)

Source: GetYourBrief — https://getyourbrief.com/entity/oscar-health
Canonical HTML page: https://getyourbrief.com/entity/oscar-health

## Recent coverage (3 stories, network-wide)

### Oscar Health Stock Under Scrutiny as Copay Accumulator Shifts $7,600 Cost to Patient
2026-07-27 11:00:41 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Oscar Health's use of a copay accumulator program has drawn attention to how insurers manage medical loss ratios. By not counting manufacturer assistance, insurers keep claims low, but regulatory and reputational risks could affect investor outlook.
Full story: https://getfinancebrief.com/story/copay-accumulator-insurer-financial-impact

### Insurer Pocketed $7,700/Month Drug Coupon, Forcing Patient to Pay $10,600
2026-07-27 11:00:04 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Copay accumulator programs are shifting thousands in drug costs back to patients, causing financial distress and potential treatment delays. Larry Gruber’s experience with Oscar Health highlights the human toll of insurance practices that prioritize cost over care.
Full story: https://gethealthbrief.com/story/copay-accumulator-patient-impact

### Amgen's Enbrel Copay Assistance Nullified: Insurer Seizes $7,700/Month Coupon
2026-07-27 10:59:55 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Drugmaker copay assistance programs are meant to lower barriers to high-cost specialty drugs, but accumulator programs circumvent them. For Amgen and other pharma companies, this practice threatens patient adherence and undermines the value of patient support initiatives.
Full story: https://getbiobrief.com/story/copay-accumulator-pharma-strategy

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.